Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
95 hedge funds and large institutions have $141M invested in Sciclone Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 41 reducing their positions, and 14 closing their positions.
151% more call options, than puts
Call options by funds: $409K | Put options by funds: $163K
15% more capital invested
Capital invested by funds: $122M → $141M (+$18.8M)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
1% less funds holding
Funds holding: 96 → 95 (-1)
41% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$4.96M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.15M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$630K |
| 4 |
Norges Bank
Oslo,
Norway
|
+$525K |
| 5 |
SAM
Shell Asset Management
The Hague,
Netherlands
|
+$481K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.5M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.28M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.24M |
| 4 |
DC
Deere & Company
Moline,
Illinois
|
-$706K |
| 5 |
QBFM
QS Batterymarch Financial Management
New York
|
-$435K |
SCLN Hedge Fund Activity: Q2 2014 in Review
95 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q2 2014, worth a combined $141M — up 15% from $122M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of SCLN and 13 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 24 added.
The largest buyer was Franklin Resources, adding an estimated $4.96M. The largest seller was BlackRock Institutional Trust, cutting an estimated $1.5M.
- 95 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q2 2014, down from 96 in Q1 2014.
- Funds reported $141M of Sciclone Pharmaceuticals Inc stock for Q2 2014, up 15% quarter-over-quarter.
- 13 funds opened new Sciclone Pharmaceuticals Inc positions in Q2 2014 and 14 closed out, a net change of -1 holder.
- The largest Sciclone Pharmaceuticals Inc buyer in Q2 2014 was Franklin Resources, an estimated $4.96M added.
- The largest Sciclone Pharmaceuticals Inc seller in Q2 2014 was BlackRock Institutional Trust, an estimated $1.5M sold.
Based on aggregated 13F filings for Q2 2014.